States and cities continue 'sweetening the deal' with vaccination incentives for young kids


With young kids ages 5 to 11 now eligible for Pfizer and BioNTech's COVID-19 vaccine, the shot incentives we've all grown to know and love (and in some cases ignore) will, in some places, continue "sweetening the deal," CNN reports.
In New York City, kids are eligible for $100 or tickets to city attractions (like the Statue of Liberty) if they receive their first dose at a city-operated vaccine site. "We really want kids to take advantage, families take advantage of that," said Mayor Bill de Blasio on Thursday. "We want our kids and our families to be safe."
A similar $100 gift card is available for Chicago children ages 5 to 11 if they get their shot at one of the city's public heath events or clinics, reports CNN. Chicago's large school district is even closing on Nov. 12 for a Vaccination Awareness Day, allowing students an opportunity to get their shots without missing class.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"It is rare that we make a late change to the school calendar, but we see this as an important investment in the future of this school year and the health and wellbeing of our students, staff, and families," Chicago Schools Chief Executive Officer Pedro Martinez told parents, per CNN.
The $100 reward could also soon be available in Louisiana, officials said. And in San Antonio, Texas, any parent or guardian that gets their child vaccinated at a public health clinic is eligible for a $100 grocery store gift card.
As of Thursday, the U.S. had fully vaccinated over 58 percent of its total population, according to CDC data. Read more at CNN.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Bluetoothing: the phenomenon driving HIV spike in Fiji
Under the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Marisa Silver’s 6 favorite books that capture a lifetime
Feature The author recommends works by John Williams, Ian McEwan, and more
-
Book reviews: ‘We the People: A History of the U.S. Constitution’ and ‘Will There Ever Be Another You’
Feature The many attempts to amend the U.S. Constitution and Patricia Lockwood’s struggle with long Covid
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts